INS and diabetes mellitus: Nearly all insulin-treated patients with diabetes utilize basal insulin, and while there are pharmacokinetic (PK) and potency differences across available basal insulins, all are full agonist insulin analogs, as is also true for the rapid acting insulin analogs.